Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Cochlear ( (AU:COH) ) has shared an announcement.
Cochlear Limited has launched the Nucleus Nexa System, the world’s first smart cochlear implant system with upgradeable firmware. This system allows users to access future innovations and features through both the implant and sound processor, enhancing the hearing experience. The Nucleus 8 Nexa Sound Processor, part of this system, is the smallest and lightest on the market, offering all-day battery life and advanced power management. The launch marks a significant advancement in cochlear implant technology, potentially improving patient outcomes and reducing clinic visits.
The most recent analyst rating on (AU:COH) stock is a Buy with a A$311.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited is a leading company in the medical device industry, specializing in cochlear implants and hearing solutions. The company focuses on developing innovative products that enhance hearing experiences for individuals with hearing impairments.
Average Trading Volume: 190,089
Technical Sentiment Signal: Hold
Current Market Cap: A$17.63B
For detailed information about COH stock, go to TipRanks’ Stock Analysis page.